We consent to the incorporation by reference in the registration statements (No. 333-141529 and No. 333-147024) on Form F-3 and the registration statements (No.333-148085 and No. 333-148754) on Form S-8 of XTL Biopharmaceuticals Ltd (a Development Stage Company) of our report dated May 3, 2005, with respect to the consolidated statements of operations, changes in shareholders' equity and cash flows of XTL Biopharmaceuticals Ltd. (a Development Stage Company) and its subsidiary for the period from March 9, 1993 to December 31, 2000, which report appears in the December 31, 2007, annual report on Form 20-F of XTL Biopharmaceuticals Ltd (a Development Stage Company).